Given the scripted nature placed on pharma sales reps and their communication with doctors, do new technologies such as chat bots create the opportunity to deliver these messages in a better way? Chatbots can provide a convenient and cost-effective way for doctors and pharma sales reps to communicate, enabling doctors to access the product information
Do you want to boost your lead generation and increase GP touchpoints 6-fold? The new Access.PLUS Sample and Service requests package has already proved itself with 2,000+ doctor lead generations and 3,000+ sample requests for 10 pharma companies. The package is designed to improve the efficiency of your field force by generating more touchpoints for
GPs have a low understanding of the difference between medical science liaisons (MSLs) and pharmaceutical sales reps, according to a recent survey conducted by AusDoc.1 The finding is unsurprising, given that MSLs generally focus on other specialists. But the increasing complexity of GP work means they will likely receive increasing MSL attention in the future.
The recent Veeva Pulse Field Trends Report 2Q22[i] provided valuable insight into when, where and how field teams and healthcare professionals interact with the pharmaceutical industry representatives. However, the global report didn’t’ offer any Australia-specific findings. To fill this gap, Inside Healthcare conducted a similar study among AusDoc’s extensive GP database to provide deeper insights
GPs feel burdened by their workload and poorly compensated for their time, according to a survey of 750 Australian Doctor readers. More than 40% of the respondents intend to reduce their working hours in the next 12 months. In many cases, this is coupled with a change from bulk billing to private billing so they
Global report shows excitement about the potential of digital but a lack of confidence about delivery Pharma companies need to invest in the digital customer experience to add value now and in the future, according to a report by digital customer experience agency Graphite in partnership with Reuters Events. The global report titled the Contradiction Conundrum is
A hybrid model that combines reps with digital solutions is a win-win for pharmaceutical companies and GPs. With face-to-face rep engagement returning to pre-COVID levels, pharmaceutical companies have an opportunity to use digital lessons learned during the pandemic to significantly increase the reach and frequency of their GP interactions without increasing their budget. The solution
About one in three Australian GPs is a digital native,1 which has fundamental implications for go-to-market strategies and a critical impact on how pharmaceutical companies promote the quality use of their medicines. Digital natives were born after 1980 and raised in an environment in which they were surrounded by technology (Palfrey and Gasser, 2013, Prensky, 2001).
Australian prescribers have tasted digital convenience and are unlikely to return to their pre-pandemic levels of face-to-face engagement with pharmaceutical representatives. That’s according to an in-depth report published by AusDoc in 2021 and a follow-up pulse survey among Australian Doctor readers conducted in January 2022[i]. The report titled How a GP initiated engagement model could
Being a member of the academic elite doesn’t necessarily make a good doctor, an AusDoc survey has revealed. From an experienced doctor’s perspective, high-achieving academics can face problems in practice. “Almost only the academic elite enter the system. This doesn’t necessarily make the best doctors…they are not used to failure and uncertainty and the hospital,
COVID-19 changed GP engagement permanently. A leading modelling expert explains why digital GTM channels are now essential for pharma companies wanting to reach Australian doctors.
GP registrars carry enormous responsibility with limited experience. AusDoc research reveals 5 practical ways pharma can support registrar confidence and build early HCP relationships.
